ONWARD Medical

ONWARD Medical is a medical technology company developing neurostimulation therapies and brain-computer interface technologies intended to restore movement, function, and independence for people with spinal cord injury. Headquartered in Eindhoven, the Netherlands, it is listed on Euronext Amsterdam under the ticker ONWD.

The company's ARC Therapy platform forms the basis of its product pipeline. The ARC-EX System is a non-invasive spinal cord stimulation device and the first FDA-cleared technology indicated to improve hand sensation and strength in people with chronic incomplete cervical spinal cord injury. ARC-IM is an investigational implantable spinal cord stimulation system, and brain-computer interface technologies are being developed alongside the ARC platforms.

ONWARD Medical has received ten FDA Breakthrough Device Designation awards and holds nearly 400 issued or pending patents. It recently raised over EUR 40 million in capital. The company employs a multidisciplinary team of scientists, engineers, and physicians working on spinal cord stimulation, brain-computer interfaces, and medical device development.